Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Applied Clinical Medical Physics|March 23, 2021
Commissioning cranial single-isocenter multi-target radiosurgery for the Versa HDCory Knill, Raminder Sandhu, Robert Halford, et al.Journal of Medical Physics|September 27, 2021
Simultaneous Optimization of Radiation-Imaging Coincidence for a Multi-Energy LinacCory Knill, Raminder Sandhu, Robert Halford, et al.Medical Physics|December 9, 2020
Technical Note: FLASH radiotherapy monitor chamber signal conditioningMichael Snyder, Jessica Vadas, John Musselwhite, et al.Journal of Applied Clinical Medical Physics|July 11, 2023
Commissioning and validation of a Monte Carlo algorithm for spine stereotactic radiosurgeryCory Knill, Raminder Sandhu, Brian Loughery, et al.Medical Physics|February 8, 2013
Commissioning of intensity modulated neutron radiotherapy (IMNRT)Jay Burmeister, Robyn Spink, Liang Liang, et al.Journal of Applied Clinical Medical Physics|May 12, 2016
Modeling the Agility MLC in the Monaco treatment planning systemMichael Snyder, Robert Halford, Cory Knill, et al.Journal of Applied Clinical Medical Physics|July 23, 2024
Evaluating stereotactic accuracy with patient-specific MRI distortion corrections for frame-based radiosurgeryCory Knill, Robert Halford, Raminder Sandhu, et al.Journal of Applied Clinical Medical Physics|March 13, 2018
Commissioning of a dedicated commercial Co-60 total body irradiation unitJay Burmeister, Adrian Nalichowski, Michael Snyder, et al.Investigational New Drugs|January 29, 2013
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortiumSrikala S Sridhar, Mary J Mackenzie, Sebastien J Hotte, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranibSuzanne Richter, Jo-An Seah, Gregory R Pond, et al.Pageof 1